# "A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"

> **NCT00365846** · PHASE2 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 29 (actual)

## Conditions studied

- Renal Transplant

## Interventions

- **DRUG:** Campath-1H

## Key facts

- **NCT ID:** NCT00365846
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-08
- **Primary completion:** 2005-07
- **Final completion:** 2006-07
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2012-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00365846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00365846, ""A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00365846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*